STOCK TITAN

BioMarin to Present at 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, at 10:30 am PT /1:30 pm ET, in San Francisco, CA

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 10:30 am PT in San Francisco, California. CEO Jean-Jacques Bienaimé will lead the presentation. Interested investors can access the live webcast on www.biomarin.com. The replay will be available for a week post-event.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Jan. 4, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at  the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, at 10:30 am PT / 1:30 pm ET, in San Francisco, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event. 

About BioMarin

Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors/Media
Traci McCarty 
BioMarin Pharmaceutical Inc.
(415) 455-7558 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-41st-annual-jp-morgan-healthcare-conference-on-monday-january-9-at-1030-am-pt-130-pm-et-in-san-francisco-ca-301712844.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin presenting at the J.P. Morgan Healthcare Conference?

BioMarin will present on January 9, 2023, at 10:30 am PT.

Who is presenting for BioMarin at the conference?

CEO Jean-Jacques Bienaimé will present for BioMarin.

Where is the J.P. Morgan Healthcare Conference taking place?

The conference is held in San Francisco, California.

How can I access the BioMarin presentation?

The presentation can be accessed via live webcast on BioMarin's investor website.

Is there a replay available for the BioMarin presentation?

Yes, a replay will be available on BioMarin's website for at least one week after the event.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

13.24B
190.58M
0.89%
99.92%
2.94%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO